Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
14m agoGoodman Group Announces Results of Cash Tender Offer for its 3.700% Guaranteed Senior Notes due 2028
15m agoFGR enters agreement to acquire advanced graphene coatings companies
15m agoH2G Green Limited's GasHub Commissions Major LNG Facility for Renowned Large-Scale Laundry Provider
1h agoEducational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach
1h agoAgibank Closes Second FIDC Structuring, Raises R$2.5 Billion
Newamsterdam Pharma Company N.v. Ordinary Shares logo

Newamsterdam Pharma Company N.v. Ordinary Shares

About

Newamsterdam Pharma Company N.v. Ordinary Shares (NASDAQ:NAMS) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 8 2026
NewAmsterdam Pharma to Present at the 25th Annual Needham Virtual Healthcare Conference
Mar 23 2026
NewAmsterdam Pharma Announces Three Presentations at the 2026 American College of Cardiology Annual Scientific Session
Feb 18 2026
NewAmsterdam Pharma Reports Full Year 2025 Financial Results and Provides Corporate Update
Feb 4 2026
NewAmsterdam Pharma to Present at the Guggenheim Emerging Outlook: Biotech Summit
Jan 9 2026
NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities

Financials

Revenue
$22.5 M
Market Cap
$3.79 B
EPS
-1.72

Community Chat

Ask AI

6ix6ix